| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Former Director
2 companies
Debbane Raymond is a Director at LXRX, with reported holdings spanning 2 companies. Recent filings cover 64 purchases and 0 sales.
Our model assigns Debbane Raymond a strong insider score of 80/100, based on 11 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +38.2%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 2,000 | $1.49 | $2,980.00 | +0.1% | +36.4% | - | |
| Feb 23, 2026 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 100,000 | $1.47 | $147,000.00 | +5.5% | +36.4% | - | |
| Feb 20, 2026 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 150,000 | $1.47 | $219,755.00 | +9.1% | +51.7% | - | |
| Feb 18, 2026 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 268,497 | $1.31 | $352,889.04 | +19.4% | +61.4% | - | |
| Oct 12, 2023 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 1,000,000 | $1.10 | $1,103,956.59 | +293.4% | +39.4% | +67.3% | |
| Nov 10, 2022 | WW Ww International, Inc. | Director | Buy | 75,000 | $4.27 | $320,055.00 | +145.8% | - | - | |
| Aug 1, 2022 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 982,600 | $2.50 | $2,456,500.00 | +22.7% | -9.3% | -18.1% | |
| Sep 16, 2019 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 103,042 | $2.69 | $277,591.21 | +49.0% | - | - | |
| Sep 13, 2019 | LXRX Lexicon Pharmaceuticals, Inc. | Director | Buy | 197,473 | $2.40 | $474,759.80 | +1,531% | - | - | |
| Mar 1, 2016 | WW Ww International, Inc. | Director | Buy | 83,125 | $12.03 | $1,000,168.31 | +339.4% | - | - |